Extending indication: role of living donor liver transplantation for hepatocellular carcinoma

Satoru Todo; Hiroyuki Furukawa; Mitsuhiro Tada; Japanese Liver Transplantation Study Group

doi:10.1002/lt.21334

Extending indication: role of living donor liver transplantation for hepatocellular carcinoma

Liver Transpl. 2007 Nov;13(11 Suppl 2):S48-54. doi: 10.1002/lt.21334.

Authors

Satoru Todo¹, Hiroyuki Furukawa, Mitsuhiro Tada; Japanese Liver Transplantation Study Group

Affiliation

¹ Department of General Surgery, Hokkaido University Graduate School of Medicine, Hokkaido University, Sapporo, Japan. stodo@med.hokudai.ac.jp

PMID: 17969069
DOI: 10.1002/lt.21334

Abstract

Living donor liver transplantation. Indication of hepatocellular carcinoma. Milan criteria. United Network for Organ Sharing (UNOS) tumor staging. Alfa-fetoprotein (AFP). Protein induced by vitamin K absence or antagonism factor II (PIVKA II).

MeSH terms

Adult
Aged
Carcinoma, Hepatocellular / therapy*
Disease-Free Survival
Female
Humans
Japan
Liver Neoplasms / therapy*
Liver Transplantation / methods*
Living Donors*
Male
Medical Oncology / methods*
Middle Aged
Recurrence
Treatment Outcome